Award recordCONTRACT

SEQIRUS USA INC

PIID 36C26018N0687· VHA· 260-NETWORK CONTRACT OFFICE 20 (36C260)· 6505 · DRUGS AND BIOLOGICALS· FY2018· $472,675 net obligations· UEI N6U7P2B9VHS5· NJ

Description

PORTLAND 18-19 INFLUENZA AFLURIA AND FLUAD: MOD TO INCREASE QUANTITY.

Base award description: PORTLAND 18-19 INFLUENZA AFLURIA AND FLUAD

First action · last action
2018-03-20 · 2018-11-29
Transactions
2
First transaction's obligation
$423,570
Base + all options value (sum of deltas)
$472,675
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
36E79718C0011
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$472,675$0Base award · 2018-03-20 · this action $423,570 · running total $423,570Modification P00001 · 2018-11-29 · this action $49,105 · running total $472,675
  • Base2018-03-20+$423,570= $423,570
  • Mod P000012018-11-29+$49,105= $472,675
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2018-03-20+$423,570$423,570PORTLAND 18-19 INFLUENZA AFLURIA AND FLUAD
Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2018-11-29+$49,105$472,675PORTLAND 18-19 INFLUENZA AFLURIA AND FLUAD: MOD TO INCREASE QUANTITY.

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI N6U7P2B9VHS5)

AwardOffice · PSC / listingNet obligationsFY
36C24626N0645246-NETWORK CONTRACTING OFFICE 6 (36C246) · 6505 · DRUGS AND BIOLOGICALS$167,990FY2026
36C26026N0271260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$69,996FY2026
36C24526N0409245-NETWORK CONTRACT OFFICE 5 (36C245) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES$125,993FY2026
36C24526N0395245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$151,658FY2026
36C24526N0422245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$130,659FY2026
36C24526N0427245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$186,656FY2026

Other recipients under 6505 from 260-NETWORK CONTRACT OFFICE 20 (36C260) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26026F0379COSETTE PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$3,466FY2026
36C26026P0671MCKESSON PLASMA AND BIOLOGICS LLC260-NETWORK CONTRACT OFFICE 20 (36C260)$18,262FY2026
36C26026F0349AGIOS PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$73,080FY2026
36C26026F0306BRACCO DIAGNOSTICS INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$337,422FY2026
36C26026F0298PROGENICS PHARMACEUTICALS INC260-NETWORK CONTRACT OFFICE 20 (36C260)$469,134FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26018N0687_3600_36E79718C0011_3600 · retrieved 2026-09-26.